MDAI (5,6-Methylenedioxy-2-aminoindane) is commonly used in preclinical scientific research focused on the serotonergic system. As a non-neurotoxic selective serotonin releasing agent (SSRA), it provides a powerful tool for studying emotional regulation, prosocial behavior, and alternative models to MDMA in both in vitro and in vivo settings. Due to its unique pharmacological profile, MDAI helps researchers explore neurotransmitter function without the severe neurotoxic risks associated with traditional amphetamines.

• Serotonergic System Mapping
  MDAI allows researchers to isolate the effects of serotonin release from other neurotransmitter systems, providing insights into mood regulation, neuroplasticity, and behavioral activation.

• Empathogenic Behavior Studies
  In animal models, MDAI is used to replicate prosocial or empathy-like behaviors, making it valuable for studying compounds with potential therapeutic relevance to disorders like PTSD and social anxiety.

• Non-Neurotoxic Substitute for MDMA
  MDAI is frequently employed in comparative studies as a non-neurotoxic alternative to MDMA, enabling safer models for long-term observation without risking serotonergic damage.

• Receptor Binding Affinity Profiling
  Researchers use MDAI to determine binding strength and selectivity toward 5-HT receptor subtypes, providing pharmacological profiles for predictive modeling.

• Toxicological and Pharmacokinetic Testing
  Its clear metabolic pathway and reduced toxicity make MDAI a candidate for assessing dose-response relationships in controlled toxicology environments.

• In Vitro Cellular Assays
  MDAI is compatible with a range of solvents and used in assays to evaluate cellular serotonin uptake, storage, and transporter affinity.

• Preclinical Behavioral Pharmacology
  Studies involving locomotor activity, grooming, and conditioned place preference are used to quantify behavioral responses and serotonergic activation.

MDAI is legal to purchase and possess for legitimate research purposes in many countries. However, the legal framework varies across jurisdictions, and researchers are expected to use the compound in full accordance with local, national, and institutional laws. RC Plug supplies MDAI strictly as a research chemical, not intended for human or veterinary use.

• Not Scheduled Under UN Conventions
  MDAI is not internationally scheduled by the United Nations, giving researchers in many countries access under general chemical import/export laws.

• Legally Unscheduled in the U.S. (as of current data)
  In the United States, MDAI is not classified as a controlled substance at the federal level, although it must be used for lawful research only.

• Analog Laws in Some Countries
  Certain regions, including parts of Europe and Australia, apply analogue laws which may interpret MDAI as similar to restricted substances. It is the buyer’s responsibility to verify local compliance.

• No Prescription Required for Research Use
  Since MDAI is not a pharmaceutical product, prescriptions are not necessary for laboratory orders, provided it is not administered to humans or animals.

• Customs Documentation Available
  RC Plug offers full documentation on request, including CAS numbers and chemical specifications, to facilitate customs clearance for research facilities.

• Institutional or Academic Approval May Be Required
  Some organizations require documented use protocols or lab safety justifications before purchasing unscheduled psychoactive compounds like MDAI.

Our MDAI stands out in the research marketplace due to its verified purity, consistent batch integrity, and transparent quality assurance protocols. RC Plug supplies MDAI that meets the expectations of pharmacologists, chemists, and neuroscientists seeking a reliable and safe compound for repeatable experiments.

• ≥99% HPLC-Verified Purity
  Each batch is analyzed using high-performance liquid chromatography (HPLC) and mass spectrometry to ensure the product meets or exceeds 99% chemical purity, essential for sensitive research.

• Independent Third-Party Testing
  We do not rely solely on internal checks. Our MDAI is validated by external labs, with certificates of analysis (COA) available upon request for full transparency.

• Batch-to-Batch Consistency
  Our synthesis and purification processes ensure that every batch maintains the same physical and chemical profile, reducing variability in long-term studies.

• Moisture-Proof, Airtight Packaging
  We use tamper-resistant containers with desiccant inclusion to guard against humidity and contamination during shipping and storage.

• Free from Contaminants and Adulterants
  Our MDAI is guaranteed to contain no fillers, binders, or undisclosed synthetic analogues, which is critical for controlled laboratory work.

• Scientifically Accurate Labeling
  Each unit is clearly marked with the batch number, CAS number, molecular weight, and date of synthesis, making it easy to integrate into formal research environments.

Proper storage of MDAI is essential for maintaining chemical stability, ensuring safety, and preventing degradation over time. MDAI’s hygroscopic nature and sensitivity to heat and light require adherence to controlled environmental standards, especially in long-term projects where chemical consistency is paramount.

• Temperature Range: 2–8°C
  We strongly recommend storing MDAI in a refrigerator or temperature-controlled environment. This slows down degradation and preserves the compound’s structural integrity.

• Avoid Humidity
  MDAI is hygroscopic and will absorb moisture from the air, potentially compromising its crystalline form and chemical stability. Always keep it in a sealed, desiccated container.

• Use Airtight Containers
  After initial access, return the product to its original airtight vial. Exposure to oxygen and atmospheric particles can lead to oxidation or contamination.

• Protect from Light
  Store MDAI in opaque or amber-colored containers, or keep it in a dark place. UV light can break molecular bonds over time and alter effectiveness.

• Clearly Label Storage Units
  Mark containers with the date of receipt, batch number, and re-testing date if needed, to help manage research inventory.

• Segregate from Volatile Substances
  Keep away from volatile chemicals, acids, or bases in the lab. Vapors and reactions from nearby materials can compromise MDAI purity.

Available scientific literature and experimental data suggest that MDAI is not neurotoxic under standard research conditions. Unlike compounds such as MDMA, which have been shown to damage serotonergic neurons with repeated exposure, MDAI offers a cleaner pharmacological profile without long-term neurotoxic effects in animal models.

• No Evidence of Serotonergic Neurodegeneration
  Multiple in vivo studies show that MDAI does not cause the depletion of serotonin neurons, a common indicator of neurotoxicity in substances like MDMA.

• Selective Serotonin Releasing Action
  MDAI is a pure SSRA, meaning it targets serotonin release specifically, avoiding the overexcitation of dopaminergic and noradrenergic systems that often lead to excitotoxicity.

• Low Mitochondrial Impact
  Research shows minimal mitochondrial stress or apoptosis in cells exposed to MDAI, a strong indicator of neurochemical safety in vitro.

• Absence of Hyperthermic Response
  In animal models, MDAI does not induce the dangerous hyperthermia associated with neurotoxic amphetamines, contributing to a more stable research profile.

• Ideal for Longitudinal Behavioral Studies
  Because it avoids the long-term damage seen in other empathogens, MDAI is preferred for chronic administration studies where neurological health is a variable.

• Safer for Comparative Assays
  MDAI allows researchers to compare serotonergic activity without introducing the confounding variable of neurotoxicity, ensuring more accurate data interpretation.

Yes, MDAI is frequently employed in laboratory settings as a non-neurotoxic alternative to MDMA, especially in studies investigating empathy, mood enhancement, and serotonergic activation. While MDAI and MDMA share similar qualitative effects in animal models, their pharmacological profiles differ significantly. Researchers turn to MDAI when they need to avoid MDMA’s well-documented neurotoxicity, uncontrolled stimulant action, and legal restrictions.

• Empathogenic Behavioral Effects
  MDAI replicates the empathogenic and mood-elevating effects of MDMA in rodents and other animal models, making it suitable for social behavior studies without the associated neurochemical risks.

• Selective Serotonin Release vs. Triple Monoamine Action
  Unlike MDMA, which also releases dopamine and norepinephrine, MDAI acts primarily on serotonin. This makes it ideal for studies requiring isolated serotonergic activity without dopaminergic stimulation.

• Reduced Legal Complexity
  As MDAI is unscheduled in many jurisdictions, it is more accessible to researchers compared to MDMA, which is a controlled substance in most countries and requires special licensing.

• Lower Neurotoxicity
  MDMA is known to cause serotonergic neurodegeneration with repeated dosing, whereas MDAI does not exhibit similar toxic effects, making it safer for long-term or repeated-trial designs.

• Slower Onset and Longer Duration
  MDAI generally has a longer duration of action with a more gradual onset, which can be preferable in studies that focus on sustained mood or behavioral change rather than acute stimulation.

• Less Likely to Cause Hyperstimulation
  MDAI produces less locomotor activity than MDMA, reducing variables in behavioral research that could be influenced by excessive movement or agitation.

MDAI is typically supplied in its most stable and lab-compatible form — a crystalline powder. This format ensures long-term integrity and flexibility in dosage measurement for various in vitro and in vivo research applications. At RC Plug, our MDAI powder is packaged with precision to preserve quality throughout transit and storage.

• Crystalline Powder
  MDAI is delivered as an off-white to beige crystalline powder, ideal for accurate weighing, solubilization, and visual purity inspection.

• Fine or Medium Granularity
  Depending on the batch, the particle size may be fine or medium. We maintain particle consistency within each lot for reproducibility across tests.

• Sealed in Airtight Containers
  Each unit is vacuum-sealed in a moisture-proof vial or foil pouch with an optional desiccant to prevent degradation and contamination.

• Pre-Labeled for Lab Use
  Labels include chemical name, CAS number, batch ID, molecular weight, and synthesis date for traceability and regulatory compliance.

• No Additives or Binders
  Our MDAI is unadulterated and free from excipients, binders, or cutting agents, making it suitable for high-purity laboratory applications.

The method of MDAI administration in research depends on the nature of the study, but it is primarily used in in vitro cellular experiments and in vivo rodent models. Researchers must follow institutional protocols and ethical guidelines when conducting studies with any psychoactive research chemical.

• In Vitro Solubilization
  MDAI is dissolved in solvents like DMSO or ethanol and used in receptor binding or neurotransmitter uptake inhibition assays on cultured cells.

• Oral or Intraperitoneal Dosing in Animals
  In animal models, MDAI may be administered orally or via intraperitoneal injection to measure behavioral or neurochemical changes under ethical research approval.

• Microdialysis Studies
  MDAI can be administered before performing in vivo microdialysis to monitor neurotransmitter levels in specific brain regions over time.

• Open Field Behavioral Tests
  After administration, subjects may be observed in open field arenas to measure sociability, exploratory behavior, or grooming.

• Controlled Dose-Response Studies
  Researchers often use ascending dose designs to assess tolerance, efficacy, and safety over multiple trials.

• Neurochemical Analysis Post-Exposure
  Brain tissue can be extracted post-experiment for HPLC analysis of neurotransmitter content, verifying MDAI’s selective action on serotonin.

MDAI is chemically stable in a number of laboratory-grade organic solvents, making it suitable for a wide range of experimental applications. However, its poor water solubility must be considered during protocol design, particularly in in vitro assays or pharmacokinetic preparations.

• Ethanol (EtOH)
  MDAI dissolves efficiently in ethanol, a common solvent for organic compound delivery in cellular assays and tissue exposure studies.

• Dimethyl Sulfoxide (DMSO)
  DMSO is highly effective in dissolving MDAI for in vitro use and is compatible with most receptor binding or toxicity assays.

• Methanol (MeOH)
  A viable alternative to ethanol, methanol can be used to prepare stock solutions of MDAI for certain analytical or mass spectrometric procedures.

• Acetone and Isopropanol
  These solvents may dissolve MDAI under certain concentrations, but require careful handling due to volatility and cell toxicity.

• Poor Solubility in Water
  MDAI’s solubility in water is minimal, limiting its use in aqueous preparations unless dissolved first in a water-miscible organic solvent.

• Storage Considerations for Solutions
  Solutions should be prepared fresh or stored at low temperatures in amber vials to prevent photodegradation and preserve chemical integrity.

Yes. At RC Plug, we back all of our orders with a 30-day full refund or replacement policy to ensure you receive exactly what you ordered, in perfect condition. If there are issues with your MDAI order, whether due to transit, customs, or quality concerns, we’ll resolve them quickly and professionally.

• 30-Day Full Refund Guarantee
  If you’re not satisfied with your order for any valid reason, we’ll issue a full refund, no questions asked.

• Free Replacement Shipping
  If your order is delayed, lost, or arrives damaged, we’ll send you a replacement at no additional charge.

• Responsive Support Team
  Our customer service team replies to most issues within 12–24 hours, ensuring rapid resolution.

• Tracking Disputes Managed
  If a tracking number shows no movement or incorrect delivery, we’ll investigate and initiate re-shipment immediately.

• Discreet Problem Resolution
  All communication and issue resolution is handled with total discretion and professionalism to protect your privacy.

• Satisfaction Guaranteed
  We are committed to building long-term relationships with researchers. If you’re not happy, we’ll make it right — guaranteed.

Although MDAI is not known to be highly toxic, it must be treated with care in research environments. Proper handling is essential not only to ensure safety but also to preserve compound integrity and maintain lab compliance. MDAI should only be managed by trained laboratory personnel using industry-standard safety practices for chemical research.

• Use Personal Protective Equipment (PPE)
  Lab workers must wear gloves, safety goggles, and protective lab coats when handling MDAI to prevent skin or eye contact and accidental contamination.

• Handle in a Well-Ventilated Space or Fume Hood
  Conduct weighing, solution preparation, or any open container work in a chemical fume hood or ventilated lab space to avoid inhaling fine powder particles.

• Avoid Ingestion and Inhalation
  MDAI is strictly not for human or animal consumption. Accidental exposure via mucous membranes or respiratory pathways must be avoided at all costs.

• Label Containers Clearly
  All storage vials and working containers should be labeled with the substance name, concentration (if in solution), hazard status, and date opened for traceability.

• Do Not Eat or Drink Near the Work Area
  To prevent cross-contamination, never consume food or beverages in areas where MDAI is handled or stored.

• Decontaminate Work Surfaces
  After handling MDAI, wipe down all surfaces with appropriate solvents and dispose of wipes in chemical waste bins.

• Dispose of Waste Responsibly
  Follow institutional or municipal hazardous waste protocols for disposing of MDAI residues, solutions, or used containers. Do not pour MDAI into drains.

RC Plug is committed to scientific transparency, and we provide all necessary documentation to verify the authenticity, purity, and consistency of our MDAI. Whether you need formal lab reports or visual inspection cues, we ensure that our product meets rigorous analytical standards from dispatch to delivery.

• Request a Certificate of Analysis (COA)
  Every batch of MDAI is accompanied by a COA, which includes detailed purity percentages, test methodology (e.g., HPLC, GC-MS), and validation date.

• Batch Identification and Traceability
  Each product vial is marked with a batch number, allowing labs to match their sample to corresponding test data or audit trails.

• HPLC and Spectroscopic Profiles
  We use advanced analytical tools like HPLC, NMR, and mass spectrometry to confirm the chemical identity and exclude any isomers, analogues, or contaminants.

• Visual Inspection of Powder
  High-quality MDAI typically appears as an off-white to beige crystalline powder. Color changes, clumping, or odor may indicate contamination or moisture exposure.

• Third-Party Validation
  In addition to in-house testing, we engage external laboratories to certify the purity and confirm structural integrity of each new synthesis batch.

• Documented Synthesis Dates
  Each shipment includes the date of synthesis to help research teams assess freshness and manage inventory lifecycle.

• Customer Feedback and Repeat Orders
  Many of our clients are institutional labs and repeat buyers who return because of our proven product reliability. Independent research confirmation often supports our quality claims.

No. MDAI is strictly not intended for human consumption and is sold solely for laboratory research and forensic use. Its chemical properties, metabolic behavior, and physiological effects in humans are insufficiently studied and could pose serious health risks if ingested or administered improperly.

• Labeled ‘For Research Use Only’
  Every unit of MDAI shipped from RC Plug is marked with disclaimers prohibiting any non-laboratory application.

• Unregulated Safety Profile in Humans
  MDAI has not been approved by any health or regulatory body for human use, and its toxicity, long-term impact, or drug interaction profile is unknown.

• Legal Consequences
  Human use of research chemicals like MDAI may violate federal or local drug analog laws, leading to criminal liability.

• Risk of Overdose or Toxic Reaction
  The absence of human dosage guidelines makes MDAI extremely dangerous outside of a controlled lab environment.

• Ethical and Institutional Violations
  Using lab-purposed compounds outside approved study protocols breaches both ethical research standards and institutional review board (IRB) requirements.

• Potential for Unknown Metabolites
  In human bodies, MDAI may metabolize into active or toxic intermediates not yet identified in peer-reviewed toxicology.

We support both small-scale academic labs and larger institutions by offering MDAI in quantities suitable for varying research needs. Whether you’re conducting a pilot study or full-scale assay, we allow flexible order sizes while maintaining quality control and secure delivery standards.

• Small Quantities for Initial Trials
  We offer quantities starting from 250 mg, which is ideal for early-stage tests, dosing calibrations, and pilot toxicity experiments.

• Larger Quantities Available for Ongoing Research
  Bulk orders of 5g, 10g, or more are available for organizations conducting extensive experiments or requiring large-scale replicability.

• Custom Orders Accepted
  If your study demands an unconventional amount, we’re able to prepare and supply custom quantities, subject to availability and proper handling procedures.

• Bulk Pricing Discounts
  Larger volume purchases may qualify for discounted pricing. Contact our support team for quote-based orders.

• Shipping Size Limitations Based on Country
  Some countries restrict the amount of research chemicals that can be imported at once. We’ll work with you to navigate any local limitations.

• Verified Packaging for All Sizes
  Regardless of quantity, every order is packed with the same care, using tamper-resistant containers and temperature-safe packaging materials.

Yes, discretion is one of our core operational values. Every MDAI order from RC Plug is shipped in unbranded, secure packaging designed to protect both the product and your privacy. Our methods ensure minimal scrutiny at borders while maintaining compliance with shipping regulations for laboratory compounds.

• Plain Exterior Packaging
  We use simple, unmarked boxes or mailers with no logos, branding, or chemical product references on the outside.

• No Product Name on Shipping Label
  For privacy and customs clearance, we only use neutral identifiers or lab product codes — never the chemical name.

• Tamper-Proof and Vacuum-Sealed Inside
  Each container of MDAI is sealed with either foil or hard vials that resist tampering and protect against humidity or environmental exposure.

• Tracking Provided Immediately
  As soon as your order ships, we provide a secure tracking link so you can monitor the shipment through every phase.

• Support for Customs Queries
  If customs authorities require documentation, we can provide SDS, COA, and proof of research use to prevent unnecessary delays.

• No Signature Required (Optional)
  We offer no-signature delivery options in many regions to further enhance discretion and convenience, depending on local courier regulations.

In controlled laboratory animal studies, MDAI has shown a range of prosocial, mood-enhancing, and neurochemically selective effects. Its role as a serotonergic agent provides researchers with a focused compound to evaluate behavioral changes without the interference of dopamine or norepinephrine pathways. MDAI’s observable effects are especially useful for modeling mood disorders, social anxiety, and serotonergic modulation.

• Increased Sociability
  Animals administered MDAI exhibit enhanced social interaction, increased grooming, and reduced avoidance behavior — mirroring human empathogenic responses.

• Mood Stabilization
  Rodents under MDAI influence display behaviors consistent with reduced anxiety and stress, such as more time spent in open arms of elevated plus mazes.

• Stable Locomotor Activity
  Unlike stimulants, MDAI does not cause hyperactivity or erratic movement patterns, making it more appropriate for sustained behavioral observation.

• No Hallucinogenic Responses
  Unlike certain serotonergic compounds (e.g., 5-MeO-DMT), MDAI does not induce head-twitch responses or other signs of hallucination in animals.

• Neurochemical Selectivity
  Microdialysis studies confirm MDAI elevates extracellular serotonin concentrations without significantly affecting dopamine or norepinephrine.

• Low Reinforcement Potential
  Conditioned place preference studies suggest that MDAI has a low abuse profile, an advantage in addiction-related behavioral research.